Teamwork is important throughout the development of a company, but never more so than in the early stages of a startup. Charlotte Edenius, co-founder and VP Business and Clinical development at Gesynta Pharma in Sweden, knows this well. With more than 20 years experience working in the industry, she knows how important it is for biotech leaders to be good at networking and managing people.
After doing a medical degree and PhD at the Karolinska Institutet in Stockholm, Edenius decided that a career in clinical medicine and academic research was not for her and started working in drug development at what later became AstraZeneca.
When AstraZeneca started expanding rapidly in the late 90’s, Edenius felt the pull of the biotech world and joined a small startup called Biolipox as CSO. Since then she has worked in senior research and development positions at the Swedish biotechs Orexo and Medivir, as well as setting up her own consultancy firm Allmora Life Science.
In 2017, Edenius co-founded Gesynta Pharma with a group of five colleagues and friends, all working in the area of inflammation science in Sweden. The company was founded to develop a cardio-protective therapy from Orexo, which is currently being tested in early clinical trials.
What inspired you to work in industry?
I started by getting my medical degree and my PhD at the Karolinska Institutet,